Anavex Life Sciences Corp (AVXL)

[shushkin]

Started doing some DD. ANAVEX 2-73 looks interesting and results should come soon.
"We eagerly await results from the ANAVEX 2-73 Phase I clinical trial, which is scheduled for completion soon." (Press Release Source: Anavex Life Sciences Corp. On Tuesday July 26, 2011, 9:00 am EDT)

But financing is the biggest problem. They are diluting every 2, 3 months and have a huge deficit "At June 30, 2011, the Company had an accumulated deficit of $27,781,923"

Outstanding shares: 25,921,574 shares of common stock outstanding as of August 12, 2011.